NL-OMON22962招募中不适用
Docetaxel versus Docetaxel and Lapatinib in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). An open label multicenter randomized phase II study.<br>A study of the Dutch Head and Neck Cancer Group (DHNCG) (NWHHT 08-02).
The Netherlands Cancer Institute Antoni van Leeuwenhoek hospitalDutch Head and Neck Cancer Group (DHNCG)0 个研究点目标入组 74 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 74
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. ≥18 years of age;
- •2. Histologically or cytologically confirmed diagnosis of SCCHN;
排除标准
- •1. Patients previously treated with EGFR inhibitor;
- •2. Patients previously treated with Docetaxel or Paclitaxel;
研究者
相似试验
尚未招募
2 期
Docetaxel versus Docetaxel and Lapatinib in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) An open label multicenter randomized phase II study. A study of the Dutch Head and Neck Cancer Group (DHNCG) (NWHHT 08-02)SCCHN10027476NL-OMON32481Antoni van Leeuwenhoek Ziekenhuis74
招募中
3 期
Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)10038597prostate cancerNL-OMON54758Memorial Sloan Kettering Cancer Center250
进行中（未招募）
1 期
Trial comparing subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC) treated with Docetaxel vs. subjects treated with a combination of Docetaxel and Radium-223Patients with histological or cytological proof of Metastatic Castration-Resistant Prostate Cancer (mCRPC)EUCTR2018-002944-10-NLMemorial Sloan Kettering Cancer Center738
已完成
不适用
Docetaxel and Carboplatin once every 3 weeks versus weekly Docetaxel in advanced non-small cell lung cancer: a Multicenter phase III study from the Dutch Chest Physician Association.on small cell lung cancer (NSCLC)NL-OMON28184MCGDepartment Pulmonary Diseases440
终止
2 期
Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)Advanced Non-Small Cell Lung CancerNCT00783471Hellenic Cooperative Oncology Group51